menopur 600 iu
ferring legemidler as - menotropin - injeksjonsvæske, oppløsning i ferdigfylt penn - 600 iu
menopur 1200 iu
ferring legemidler as - menotropin - injeksjonsvæske, oppløsning i ferdigfylt penn - 1200 iu
stocrin 600 mg
orifarm as - efavirenz - tablett, filmdrasjert - 600 mg
rekovelle 72 mikrog/2.16 ml
2care4 aps - follitropin delta - injeksjonsvæske, oppløsning - 72 mikrog/2.16 ml
livopan 50 % v/v / 50 % v/v
aga ab - dinitrogenoksid / oksygen - medisinsk gass, komprimert - 50 % v/v / 50 % v/v
medisinsk lystgass nippon gases scandinavia 100 %
nippon gases norge as - dinitrogenoksid - medisinsk gass, flytende - 100 %
gonal-f 300 ie/0.5 ml
orifarm as - follitropin alfa - injeksjonsvæske, oppløsning i ferdigfylt penn - 300 ie/0.5 ml
gonal-f 900 ie/1.5 ml
orifarm as - follitropin alfa - injeksjonsvæske, oppløsning i ferdigfylt penn - 900 ie/1.5 ml
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
zeldox 20 mg
orifarm as - ziprasidonhydrokloridmonohydrat - kapsel, hard - 20 mg